Patents by Inventor Raymond F. Kauffman

Raymond F. Kauffman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of congestive heart failure with growth hormone secretagogues
    Patent number: 6329342
    Abstract: The present invention is directed to methods for the modulation of cardiac function which comprise the administration of certain compounds, as defined herein, having growth hormone secretagogue activity.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: December 11, 2001
    Assignee: Eli Lilly and Company
    Inventors: Raymond F. Kauffman, Alan D. Palkowitz
  • Methods for lowering serum cholesterol
    Patent number: 5464845
    Abstract: A method of lowering serum cholesterol levels comprising administering to a patient a serum cholesterol lowering amount of a compound having the formula ##STR1## wherein n is 0, 1 or 2;R is hydroxyl, methoxy, C.sub.1 -C.sub.7 alkanoyloxy, C.sub.3 -C.sub.7 cycloalkanoyloxy, (C.sub.1 -C.sub.6 alkoxy)-C.sub.1 -C.sub.7 alkanoyloxy, substituted or unsubstituted aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy;R.sup.1 is hydrogen, hydroxyl, chloro, bromo, methoxy, C.sub.1 -C.sub.7 alkanoyloxy, C.sub.3 -C.sub.7 cycloalkanoyloxy, (C.sub.1 -C.sub.6 alkoxy)-C.sub.1 -C.sub.7 alkanoyloxy, substituted or unsubstituted aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy;R.sup.2 is a heterocyclic ring selected from the group consisting of pyrrolidino, piperidino, or hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: November 30, 1993
    Date of Patent: November 7, 1995
    Assignee: Eli Lilly and Company
    Inventors: Larry J. Black, Henry U. Bryant, George J. Cullinan, Raymond F. Kauffman
  • Local delivery of dipyridamole for the treatment of proliferative diseases
    Patent number: 5314688
    Abstract: A method of inhibiting cell proliferation in mammals which comprises the local delivery of an inhibitory amount of dipyridamole. Inhibiting cell proliferation is useful for the treatment of proliferative diseases such as vascular restonesis, scleroderma, psoriasis, and rheumatoid arthritis. This method includes the local delivery of dipyridamole to the proliferative site by various techniques including local delivery catheters, site specific carriers, implants, direct injection, or direct application.
    Type: Grant
    Filed: February 9, 1993
    Date of Patent: May 24, 1994
    Assignee: Eli Lilly and Company
    Inventors: Raymond F. Kauffman, Jai P. Singh
  • Local delivery of dipyridamole for the treatment of proliferative diseases
    Patent number: 5270047
    Abstract: A method of inhibiting cell proliferation in mammals which comprises the local delivery of an inhibitory amount of dipyridamole. Inhibiting cell proliferation is useful for the treatment of proliferaive diseases such as vascular restonesis, scleroderma, psoriasis, and rheumatoid arthritis. This method includes the local delivery of dipyridamole to the proliferative site by various techniques including local delivery catheters, site specific carriers, implants, direct injection, or direct application.
    Type: Grant
    Filed: November 21, 1991
    Date of Patent: December 14, 1993
    Inventors: Raymond F. Kauffman, Jai P. Singh